Table 2

HR and IRD estimates (with 95% CIs and p values) for associations between an increase of 1-unit in the iAUC-transformed weighted SD measure of each PPL parameter and incident CHD or stroke

PPL parameter	Model	N	Events	HR (95% CI)	p Value	IRD* (95% CI)	p Value
TG	Crude	534	123	0.94 (0.80 to 1.11)	0.459	−4.1 (−12.4 to 5.0)	0.382
	Age and sex	534	123	0.93 (0.80 to 1.10)	0.414	−3.3 (−14.2 to 3.9)	0.386
	Fully adjusted†	519	117	0.95 (0.80 to 1.13)	0.557	−3.8 (−15.3 to 4.2)	0.541
TRL-TG	Crude	495	112	0.97 (0.82 to 1.15)	0.710	−2.2 (−10.1 to 6.5)	0.617
	Age and sex	495	112	0.96 (0.81 to 1.15)	0.662	−2.0 (−11.3 to 6.4)	0.588
	Fully adjusted†	480	106	0.98 (0.81 to 1.18)	0.828	−1.4 (−11.6 to 7.1)	0.674
RP	Crude	534	122	1.06 (0.89 to 1.25)	0.532	2.3 (−5.7 to 10.6)	0.558
	Age and sex	534	122	1.05 (0.89 to 1.25)	0.565	1.1 (−4.5 to 9.2)	0.552
	Fully adjusted†	519	116	1.07 (0.90 to 1.28)	0.437	1.3 (−5.2 to 9.4)	0.517
apoBR	Crude	485	112	0.91 (0.76 to 1.10)	0.340	−1.2 (−9.8 to 7.5)	0.679
	Age and sex	485	112	0.91 (0.76 to 1.10)	0.344	−1.3 (−11.0 to 7.3)	0.698
	Fully adjusted‡	470	106	0.93 (0.77 to 1.13)	0.460	−1.5 (−12.3 to 6.7)	0.706

*Estimate of IRD per 1000 person-years.
†Adjusted for age, sex, race and fasting blood glucose, following stepwise selection.
‡Adjusted for age, sex, race, fasting blood glucose and current smoking status, following stepwise selection.
apoBR, apolipoprotein B100 ratio; IRD, incident rate difference; PPL, postprandial lipemia; RP, retinyl palmitate; TG, postprandial triglycerides; TRL-TG, TG-rich lipoprotein triglycerides.